933
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

Reassortment of high-yield influenza viruses in vero cells and safety assessment as candidate vaccine strains

, , , , , & show all
Pages 111-116 | Received 04 Apr 2016, Accepted 29 Aug 2016, Published online: 17 May 2017

References

  • Osterhaus A, Fouchier R, Rimmelzwaan G. Towards universal influenza vaccines? Philosophical transactions of the Royal Society of London Series B. Biol Sci 2011; 366:2766-73; PMID:21893539; http://dx.doi.org/10.1098/rstb.2011.0102
  • Hoffmann E, Webster RG. Unidirectional RNA polymerase I-polymerase II transcription system for the generation of influenza A virus fromeight plasmids. J Gen Virol 2000; 81:2843-47; PMID:11086114; http://dx.doi.org/10.1099/0022-1317-81-12-2843
  • Wright PF. Vaccine preparedness–are we ready for the next influenza pandemic?. N Engl J Med 2008; 358:2540-3; PMID:18550873; http://dx.doi.org/10.1056/NEJMp0803650
  • Liu Z, Li WD, Sun MB, Ma L, Guo ZQ, Jiang SD, Liao GY, Yang JS, Li CG. Screening of a high growth influenza B virus strain in Vero cells. Virol Sin 2010; 25:65-70; PMID:20960286; http://dx.doi.org/10.1007/s12250-010-3066-8
  • Montagnon BJ. Polio and rabies vaccines produced in continuous cell lines: a reality for Vero cell line. Dev Biol Stand 1989; 70:27-47; PMID:2759353
  • Smith LR, Wodal W, Crowe BA, Kerschbaum A, Bruehl P, Schwendinger MG, Savidis-Dacho H, Sullivan SM, Shlapobersky M, Hartikka J, Rolland A, Barrett PN, Kistner O. Preclinical evaluation of Vaxfectin-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines. Hum Vaccin Immunother 2013; 9:1333-45; PMID:23857272; http://dx.doi.org/10.4161/hv.24209
  • Stittelaar KJ, Veldhuis Kroeze EJ, Rudenko L, Dhere R, Thirapakpoomanunt S, Kieny MP, Osterhaus AD. Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets. Vaccine 2011; 29:9265-70; PMID:21945964; http://dx.doi.org/10.1016/j.vaccine.2011.09.049
  • Van der Velden MV, Fritz R, Pöllabauer EM, Portsmouth D, Howard MK, Kreil TR, Dvorak T, Fritsch S, Vesikari T, Diez-Domingo J, et al. Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population. J Infect Dis 2014; 209:12-23; PMID:24041789; http://dx.doi.org/10.1093/infdis/jit498
  • Keitel WA, Dekker CL, Mink C, Campbell JD, Edwards KM, Patel SM, Ho DY, Talbot HK, Guo K, Noah DL, et al. Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults. Vaccine 2009; 27:6642-8; PMID:19773098; http://dx.doi.org/10.1016/j.vaccine.2009.03.015
  • Liu X, Liu Y, Zhang Y, Chen Z, Tang Z, Xu Q, Wang Y, Zhao P, Qi Z. Pre-existing immunity with high neutralizing activity to 2009 pandemic H1N1 influenza virus in Shanghai population. PLoS One 2013; 8:e58810; PMID:23527030; http://dx.doi.org/10.1371/journal.pone.0058810
  • Ryder AB, Nachbagauer R, Buonocore L, Palese P, Krammer F, Rose JK. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against DivergentInfluenza Virus Challenge Strains. J Virol 2015; 90:2544-50; PMID:26676789; http://dx.doi.org/10.1128/JVI.02598-15
  • Sugaya N, Nerome K, Ishida M, Matsumoto M, Mitamura K, Nirasawa M. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B. JAMA 1994; 272:1122-6; PMID:7933325; http://dx.doi.org/10.1001/jama.1994.03520140052037
  • Yang X, Zhao J, Wang C, Duan Y, Zhao Z, Chen R, Zhang L, Xing L, Lai C, Zhang S, Wang X, Yang P. Immunization with a live attenuated H7N9 influenza vaccine protects mice against lethal challenge. PLoS One 2015; 10:e0123659; PMID:25884801; http://dx.doi.org/10.1371/journal.pone.0123659
  • Ugiyadi M, Tan MI, Giri-Rachman EA, Zuhairi FR, Sumarsono SH. The expression of essential components for human influenza virus internalisation in Vero and MDCK cells. Cytotechnology 2014; 66:515-23; PMID:23912187; http://dx.doi.org/10.1007/s10616-013-9602-2

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.